Paradigm Capital Management Inc Exagen Inc. Transaction History

Paradigm Capital Management Inc

  • $2.21 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022
BUY
$4.18 - $7.74 $101,528 - $187,996
24,289 Added 42.69%
81,189 $466,000
Q1 2022

May 25, 2022
BUY
$7.12 - $11.06 $108,466 - $168,488
15,234 Added 36.56%
56,900 $457,000
Q4 2021

Feb 09, 2022
BUY
$8.97 - $14.08 $373,744 - $586,657
41,666 New
41,666 $485,000

Others Institutions Holding XGN

# of Institutions
38
Shares Held
6.41M
Call Options Held
4.5K
Put Options Held
400
View Full List

About EXAGEN INC.

XGN Quotes by TradingView
  • Ticker XGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 16,260,400
  • Market Cap $89.8M
  • Description
  • Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...
More about XGN
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email